Description of Research Expertise:
Dr. Courtwright is a clinician in the Department of Pulmonary and Critical Care Medicine and the Co-Chair of the Hospital of the University of Pennsylvania Ethics Committee. His research is divided between issues in resource allocation in lung transplantation and clinical ethics consultation.
Dr. Courtwright is currently focused on three projects: 1) the impact of 1 year survival quality benchmarks on solid organ candidate selection and recipient management; 2) capturing institutional variations in ethics consultation for conflict over life-sustaining treatment, including procedural mechanisms for conflict resolution; 3) the appropriate method of detection of circulating HLA antibodies pre- and post-transplant and the impact of different screening approaches on access to lung transplantation among women and racial and ethnic minorities. In addition, he continues collaborative work in short telomere syndromes and lung transplantation with Brigham and Women’s Hospital and ethics consultation research with the Massachusetts General Hospital Ethics Committee.
Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg HJ: Clinical outcomes of lung transplantation in the presence of donor-specific antibodies. Annals of the American Thoracic Society 16 (9): 1131-1137,2019.
Courtwright AM, Rubin E, Robinson EM, Thomasson A, El-Chemaly S, Diamond JM, Goldberg HJ.: In-hospital and subsequent mortality among lung transplant recipients with a prolonged initial hospitalization. American Journal of Transplantation 19 (2): 532-9,2018.
Lamas Daniela J, Lakin Joshua R, Trindade Anil J, Courtwright Andrew, Goldberg Hilary: Looking beyond mortality in transplantation outcomes The New England Journal of Medicine 379 (20): 1889-1891,2018.
Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly S: Association of donor and recipient telomere length with clinical outcomes following lung transplantation. PloS One 11 (9): e0162409,2016.
Courtwright AM, El-Chemaly S, Dellaripa PF, Goldberg HJ: Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease. The Journal of Heart and Lung Transplantation 36 (7): 763-9,2017.
Cao S*, Courtwright AM*, Lamattina A, Guleria I, Burkett P, El-Chemaly S, Goldberg HJ.: The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study. Journal of Heart and Lung Transplantation 37 (4): 531-3,2018.
Courtwright AM, Robinson EM, Feins K, Carr-Loveland J, Donahue V, Roy N, McCannon J: Ethics committee consultation and extracorporeal membrane oxygenation. Annals of the American Thoracic Society 13 (9): 1553-1558,2016.
Robinson EM, Cadge W, Zollfrank AA, Cremens MC, Courtwright AM: After the DNR: Surrogates who persist in requesting cardiopulmonary resuscitation. The Hastings Center Report 47 (1): 10-19,2017.
Courtwright AM, Brackett S, Cadge W, Krakauer EL, Robinson EM: Experience with a hospital policy on not offering cardiopulmonary resuscitation when believed more harmful than beneficial. Journal of Critical Care 30 (1): 173-7,2015.
Courtwright, AM: Stigmatization and public health ethics. Bioethics 27 (2): 74-80,2011.